Neuropeptide Y is released from human mammary and radial vascular biopsies and is a functional modulator of sympathetic cotransmission

Journal of Vascular Research

Volumn 41, Issue 5, 2004, Pages 387-399

  Donoso, M V ^a   Miranda, R ^a   Irarrazaval M J ^a   Huidobro Toro, J Pablo ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Human mammary vessels; Human radial artery; Neuropeptide Y; Neuropeptide Y release; Sympathetic cotransmission; Vascular sympathetic reactivity

Indexed keywords

ADENOSINE TRIPHOSPHATE; GUANETHIDINE; NEUROPEPTIDE Y; NORADRENALIN; TISSUE EXTRACT;

ADULT; AGED; ARTICLE; BLOOD VESSEL BIOPSY; BLOOD VESSEL TONE; CARDIOVASCULAR SYSTEM; CHROMATOGRAPHY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; ELECTROSTIMULATION; EXTRACELLULAR CALCIUM; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MAMMARY ARTERY; NEUROMODULATION; OXIDATION KINETICS; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN SECRETION; RADIAL ARTERY; STANDARD; SYMPATHETIC TONE; VASOMOTOR REFLEX;

ADENOSINE TRIPHOSPHATE; ADRENERGIC FIBERS; AGED; BIOPSY; CALCIUM; DRUG SYNERGISM; ELECTRIC STIMULATION; FEMALE; GUANETHIDINE; HUMANS; MALE; MAMMARY ARTERIES; MIDDLE AGED; NEUROPEPTIDE Y; NOREPINEPHRINE; RADIAL ARTERY; RECEPTORS, NEUROPEPTIDE Y; SYMPATHOLYTICS; SYMPATHOMIMETICS; SYNAPTIC TRANSMISSION; VASOCONSTRICTION;

EID: 9144229324     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080900     Document Type: Article

References (41)

1. Tatemoto K: Neuropeptide Y: Complete amino acid sequence of the brain peptide. Proc Natl Acad Sci USA 1982;79:5485-5489.
2. Lundberg JM, Rudehill A, Sollevi A, Fried G, Wallin G: Co-release of neuropeptide Y and noradrenaline from pig spleen in vivo: Importance of subcellular storage, nerve impulse frequency and pattern, feedback regulation and resupply by axonal transport. Neuroscience 1989;28:475-486.
3. Corder R, Emson PC, Lowry PJ: Purification and characterization of human neuropeptide Y from adrenal-medullary phaeochromocytoma tissue. Biochem J 1984;219:699-706.
4. Wahlestedt C, Grundemar L, Håkanson R, Heilig M, Shen GH, Zukowska-Grojec Z, Reis DJ: Neuropeptide Y receptor subtypes, Y1 and Y2. Ann NY Acad Sci 1990;611:7-26.
5. Edvinsson L, Ekblad E, Håkanson R, Wahlestedt K: Neuropeptide Y potentiates the effect of various vasoconstrictor agents on rabbit blood vessels. Br J Pharmacol 1984;83:519-525.
6. 2 receptors. Eur J Pharmacol 1995;294:391-401.
7. Donoso MV, Brown N, Carrasco C, Cortes V, Fournier A, Huidobro-Toro JP: Stimulation of the sympathetic perimesenteric arterial nerves releases neuropeptide Y potentiating the vasomotor activity of noradrenaline: Involvement of neuropeptide Y-Y1 receptors. J Neurochem 1997;69:1048-1059.
8. Macho P, Perez R, Huidobro-Toro JP, Domenech R: Neuropeptide Y: A coronary vasoconstrictor and potentiator of catecholamine-induced coronary constriction. Eur J Pharmacol 1989;167:67-74.
9. You J, Edvinsson L, Bryan RM Jr: Neuropeptide Y-mediated constriction and dilation in rat middle cerebral arteries. J Cereb Blood Flow Metab 2001;21:77-84.
10. Donoso MV, Silva M, St. Pierre S, Huidobro-Toro JP: Neuropeptide Y (NPY), an endogenous modulator of neurotransmission in the rat vas deferens: Structural and functional studies. Peptides 1988;9:545-552.
11. Grundemar L, Krstenansky JL, Håkanson R: Activation of neuropeptide Y1 and Y2 receptors by substituted and truncated neuropeptide Y analogs: Identification of signal epitopes. Eur J Pharmacol 1993;232:271-278.
12. Hegbrant J, Thysell H, Ekman R: Circulating neuropeptide Y in plasma from uremic patients consists of multiple peptide fragments. Peptides 1995;16:395-397.
13. 1 receptors in the blood pressure baroreflex: Studies with BIBP 3226 and BIBO 3304. Eur J Pharmacol 1999;376:251-255.
14. Racchi H, Irarrázabal MJ, Howard M, Morán S, Zalaquett R, Huidobro-Toro JP: Adenosine 5′-triphosphate and neuropeptide Y are cotransmitters in conjunction with noradrenaline in the human saphenous vein. Br J Pharmacol 1999;126:1175-1185.
15. Omland T, Opstad PK, Dickenstein K: Plasma neuropeptide Y levels in the acute and early convalescent phase after myocardial infarction. Am Heart J 1994;127:774-779.
16. O'Hare MMT, Schwartz T: Expression and precursor processing of neuropeptide Y in human pheochromocytoma and neuroblastoma tumors. Cancer Res 1989;49:7010-7014.
17. Tabarin A, Cassiède P, Minot AP, Cuber JC, Roger P, Ducassou D: Heterogeneity of neuropeptide Y immunoreactivity in patients with pheochromocytoma: Influence on the diagnostic power of measuring plasma NPY using antisera with different specificities. Acta Endocrinol (Copenh) 1993;128:243-250.
18. Mezzano V, Donoso MV, Capurro D, Huidobro-Toro JP: Increased neuropeptide Y pressor activity in Goldblatt hypertensive rats: In vivo studies with BIBP 3226. Peptides 1998;19:1227-1232.
19. Donoso MV, Miranda R, Briones R, Irarrázaval MJ, Huidobro-Toro JP: Release and functional role of neuropeptide Y as a sympathetic modulator in human saphenous vein biopsies. Peptides 2004;25:53-64.
20. 2-adrenoceptors control the release of noradrenaline but not neuropeptide Y from perivascular nerve terminals. Peptides 2002;23:1663-1671.
21. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
22. Stenfors C, Mathé AA, Theodorsson E: Chromatographic and immunochemical characterization of rat brain neuropeptide Y-like immunoreactivity (NPY-LI) following repeated electroconvulsive stimuli. J Neurosci Res 1995;41:206-212.
23. Feng Q, Lambert ML, Callow ID, Arnold JM: Venous neuropeptide Y receptor responsiveness in patients with chronic heart failure. Clin Pharmacol Ther 2000;67:292-298.
24. Ahlborg G, Weitzberg E, Sollevi A, Lundberg JM: Splanchnic and renal vasoconstrictor and metabolic responses to neuropeptide Y in resting and exercising man. Acta Physiol Scand 1992;145:139-149.
25. Kaijser L, Pernow J, Berglund B, Grunnström J, Lundberg JM: Neuropeptide Y release from human heart is enhanced during prolonged exercise in hypoxia. J Appl Physiol 1994;76:1346-1349.
26. Takiyyuddin MA, Brown MR, Dinh TQ, Cervenka JH, Braun SD, Parmer RJ, Kennedy B, O'Connor DT: Sympatho-adrenal secretion in humans: Factors governing catecholamine and storage vesicle peptide co-release. J Auton Pharmacol 1994;14:187-200.
27. Zukowska-Grojec Z: Neuropeptide Y. A novel sympathetic stress hormone and more. Ann NY Acad Sci 1995;771:219-233.
28. Valenzuela RF, Donoso MV, Mellado P, Huidobro-Toro JP: Migraine, but not subarachnoid hemorrhage, is associated with differentially increased NPY-like immunoreactivity in the CSF. J Neurol Sci 2000;173:140-146.
29. McCarthy JB, Walker M, Pierce J, Camp P, White JD: Biosynthesis and metabolism of native and oxidized neuropeptide Y in the hippocampal mossy fiber system. J Neurochem 1998;70:1950-1963.
30. Rahman MA, Nelson H, Weissbach H, Brot N: Cloning, sequencing, and expression of the Escherichia coli peptide methionine sulfoxide reductase gene. J Biol Chem 1992;267:15549-15551.
31. Moskovitz J, Weissbach H, Brot N: Cloning the expression of a mammalian gene involved in the reduction of methionine sulfoxide residues in proteins. Proc Natl Acad Sci USA 1996;93:2095-2099.
32. Moskovitz J, Jenkins NA, Gilbert DJ, Copeland NG, Jursky F, Weissbach H, Brot N: Chromosomal localization of the mammalian peptidemethionine sulfoxide reductase gene and its differential expression in various tissues. Proc Natl Acad Sci USA 1996;93:3205-3208.
33. Hunter LW, Rorie DK, Yaksh TL, Tyce GM: Concurrent separation of catecholamines, dihydroxyphenylglycol, vasoactive intestinal peptide, and neuropeptide Y in superfusate and tissue extract. Anal Biochem 1988;173:340-352.
34. Hunter LW, Tyce GM, Rorie DK: Neuropeptide Y release and contractile properties: Differences between canine veins and arteries. Eur J Pharmacol 1996;313:79-87.
35. Brock JA, Cunnane TC: Studies on the mode of action of bretylium and guanethidine in postganglionic sympathetic nerve fibres. Naunyn Schmiedebergs Arch Pharmacol 1988;338:504-509.
36. Przywara DA, Chowdhury PS, Bhave SV, Wakade TD, Wakade AR: Barium-induced exocytosis is due to internal calcium release and block of calcium efflux. Proc Natl Acad Sci USA 1993;90:557-561.
37. Zucker RS: Exocytosis: A molecular and physiological perspective. Neuron 1996;17:1049-1055.
38. Lundberg JM, Rudehill A, Sollevi A, Theodorsson-Norheim E, Hamberger B: Frequency- and reserpine-dependent chemical coding of sympathetic transmission: Differential release of noradrenaline and neuropeptide Y from pig spleen. Neurosci Lett 1986;63:96-100.
39. Lundberg JM, Rudehill A, Sollevi A, Hamberger B: Evidence for co-transmitter role of neuropeptide Y in the pig spleen. Br J Pharmacol 1989;96:675-687.
40. De Potter WP, Kurzawa R, Miserez B, Coen EP: Evidence against differential release of noradrenaline, neuropeptide Y, and dopamine-beta- hydroxylase from adrenergic nerves in the isolated perfused sheep spleen. Synapse 1995;19:67-76.
41. Bergdahl A, Nilsson T, Cantera L, Nilsson L, Sun XY, Hedner T, Erlinge D, Valdemarson S, Edvinsson L: Neuropeptide Y potentiates noradrenaline-induced contraction through the neuropeptide Y Y1 receptor. Eur J Pharmacol 1996;316:59-64.